Hepatitis B and the Opioid Epidemic Report
Published on: March 15, 2018
Despite the availability of a highly effective vaccine, barriers to preventing hepatitis B infection in the U.S. remain. These barriers include low rates of hepatitis B vaccination coverage among adults and increased rates of injection drug use – a major risk factor for hepatitis B (HBV), hepatitis C (HCV), and HIV infections – as the opioid epidemic in the U.S. continues.
This report is brought to you by Hep B United.
READ/PRINT THE FULL REPORT HBU-HBV-and-Opioid-Overview
